Were you affected by investment losses in CRWV securities between March 28, 2025, and December 15, 2025? Affected Investor Losses Summary CoreWeave, Inc. securities fraud class action filedPurchasers or acquirers of CoreWeave, Inc. (NASDAQ: CRWV) securitiesSeeking recovery of investment losses for material misstatements and/or omissions (as alleged) from March 28, 2025 through December 15, 2025Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) can assist at no cost to investor RADNOR, Pa., Jan. 16, 2026 (GLO ...

Core Viewpoint - A class action lawsuit has been filed against Coupang, Inc. for allegedly misleading investors about its cybersecurity practices during a specified period, leading to significant financial losses due to a data breach revelation [1][2][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Coupang securities from May 7, 2025, to December 16, 2025 [1]. - Investors have until February 17, 2026, to seek appointment as lead plaintiff representatives [2]. - The complaint claims that Coupang had inadequate cybersecurity measures, increasing the risk of a data breach [2]. Group 2: Cybersecurity Incident - In November 2025, it was disclosed that a data breach had compromised sensitive personal information of over 33 million customers [3]. - Following the breach disclosures, Coupang's stock price experienced significant declines, culminating in an acknowledgment of the cybersecurity event on December 16, 2025 [3]. - This incident is noted as the largest cybersecurity event affecting South Korea to date [3].

Core Viewpoint - A class action lawsuit has been filed against Varonis Systems, Inc. on behalf of investors who acquired Varonis securities during the specified class period, highlighting concerns over the company's financial disclosures and performance [1][3]. Company Summary - Varonis Systems, Inc. is a global security company based in Miami, Florida, specializing in software products that utilize AI technologies to detect advanced security threats [2]. - The company reported a significant miss in annual recurring revenue (ARR) and reduced its guidance for the full fiscal year 2025, attributing this to weaker than expected customer renewals and conversions in its subscription business [3]. Financial Impact - Following the announcement of disappointing financial results on October 28, 2025, Varonis' stock price plummeted from $63.00 to $32.34 per share, marking a decline of $30.66 per share, or over 48%, in just one day [4].

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. for failing to disclose significant changes affecting its cash flow during its IPO [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired StubHub securities between September 14, 2025, and November 24, 2025, including shares from the September 2025 IPO [1][2]. - Investors have until January 23, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Operations - StubHub operates a global online marketplace for buying and selling tickets for live sports, music, and entertainment events [2]. Group 3: Allegations - The complaint alleges that StubHub's IPO Registration Statement did not disclose changes in payment timing to vendors, which adversely affected the company's free cash flow [3].

Core Viewpoint - The Fermi Inc. class action lawsuit alleges violations of securities laws related to its October 2025 IPO, with claims of misleading statements regarding tenant demand and funding commitments for its Project Matador campus [2][4]. Group 1: Class Action Details - The class action lawsuit is titled Lupia v. Fermi Inc., No. 26-cv-00050 (S.D.N.Y.) and involves Fermi, its executives, and IPO underwriters [2]. - Investors who purchased Fermi common stock during the IPO or between October 1, 2025, and December 11, 2025, can seek to be appointed as lead plaintiff by March 6, 2026 [1][7]. Group 2: Allegations Against Fermi - The lawsuit claims that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment [4]. - It is alleged that there was a significant risk of the tenant terminating its funding commitment, which was not disclosed [4]. - On December 12, 2025, Fermi announced that the first tenant for Project Matador had terminated a $150 million funding agreement, leading to a nearly 34% drop in stock price [5]. Group 3: Stock Performance - Following the IPO, Fermi's stock price fell from $21.00 per share to as low as $8.59 per share, representing a 59% decline [6].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9%, from $31.54 to $29.36 [6]. - Following the Q3 2025 financial results on November 20, 2025, which included a further reduction in full year guidance and acknowledgment that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8%, from $21.04 to $15.82 [7]. Legal Proceedings - Investors have until March 13, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE:ARE) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://ww ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter due to "hindsight evaluations of historical collection trends" and increased its professional liability reserves by $54 million [5]. - Following this announcement, Ardent Health's stock price fell by $4.75 per share, a decline of over 33%, from $14.05 to $9.30 per share [5].

Company Overview - Wealthfront Corporation is described as a technology company that has developed a financial solutions platform aimed at addressing the needs of wealth builders among digital natives [3]. Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Wealthfront, focusing on whether the company and its top executives made materially false and/or misleading statements or omitted material information regarding its business and operations [3]. Law Firm Background - Robbins Geller is recognized as one of the leading law firms in the world for representing investors in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in securities-related class action cases in 2024 alone [4].

Core Viewpoint - The Varonis Systems, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims that the company misrepresented its revenue outlook and growth potential, leading to significant stock price declines [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Molchanov v. Varonis Systems, Inc., and covers purchasers of Varonis common stock from February 4, 2025, to October 28, 2025, with a deadline of March 9, 2026, for lead plaintiff applications [1][5]. - Allegations include that Varonis executives created a false impression of reliable revenue projections while downplaying risks associated with seasonality and macroeconomic factors [3]. - On October 28, 2025, Varonis reported third-quarter results that significantly missed projections, leading to a nearly 49% drop in stock price [4]. Group 2: Company Background - Varonis provides software products and services focused on data security and analytics [2]. - The company has been criticized for its inability to maintain annual recurring revenue growth without high quarterly conversion rates [3].